China Universal Asset Management Co., Ltd. Terns Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.17 Billion
- Q3 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 15,339 shares of TERN stock, worth $344,820. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,339
Previous 17,541
12.55%
Holding current value
$344,820
Previous $65,000
78.46%
% of portfolio
0.01%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding TERN
# of Institutions
152Shares Held
89.8MCall Options Held
574KPut Options Held
41.6K-
Soleus Capital Management, L.P. Greenwich, CT8.13MShares$183 Million3.76% of portfolio
-
Morgan Stanley New York, NY7.59MShares$171 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$170 Million1.96% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.5MShares$168 Million1.8% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$155 Million8.33% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $846M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...